Classer les publications sur l'année
-
Pharmaco-Epidémiologie
The SCOPE Study : Healthcare consumption related to patients with Chronic Obstructive Pulmonary Disease in France
DETOURNAY B, PRIBIL C, FOURNIER M, HOUSSET B, HUCHON G, HUAS D, GODARD P, VOINET C, CHANAL I, JOURDANNE C, DURAND-ZALESKI I, the SCOPE Group
Value Health ; 7(2):168-174
-
Pharmaco-Epidémiologie
The psychological impact of terrorism : an epidemiologic study of posttraumatic stress disorder and associated factors in victims of the 1995-1996 bombings in France
VERGER P, DAB W, LAMPING DL, LOZE JY, DESCHASEAUX-VOINET C, ABENHAIM L, ROUILLON F
Am J Psychiatry ; 161(8):1384-1389
-
Biométrie et Analyses de bases de données/SNDS
Prise en charge hospitaliĂšre et ambulatoire de la maladie veineuse thromboembolique en France : un Ă©tat des lieux
BENARD E, PRIOLLET P, DELECROIX M
J Mal Vasc ; 29(3):139-144
-
Pharmaco-Epidémiologie
Medical outcomes of glaucoma therapy from a Nationwide representative survey
DENIS P, LAFUMA A, BERDEAUX G
Clin Drug Investig ; 24(6):343-352
-
Pharmaco-Epidémiologie
EPIGRAM, Ă©tude phamacoĂ©pidĂ©miologique de l’obĂ©sitĂ© : mĂ©thodologie et critĂšres de qualitĂ©
VRAY M, JOUBERT JM, ESCHWĂGE E, LIARD F, FAGNANI F, COMMENGES B, STEINBERG G, BĂGAUD B
Thérapie ; 59(6):573-579
-
Pharmaco-Epidémiologie
Costs of rheumatoid arthritis in France : a multicenter study of 1109 patients managed by hospital-based rheumatologists
GUILLEMIN F, DURIEUX S, DAURES JP, LAFUMA A, SARAUX A, SIBILIA J, BOURGEOIS P, SANY J
J Rheumatol ; 31(7):1297-1304
-
Pharmaco-Epidémiologie
Comparison of Nd : YAG capsulotomy rates following phacoemulsification with implantation of PMMA, silicone, or acrylic intra-ocular lenses in four European countries
AUFFARTH G, BRĂZIN A, CAPOROSSI A, LAFUMA A, MENDICUTE J, BERDEAUX G, SMITH A
Ophthalmic Epidemiol ; 11(4):319-329
-
Pharmaco-Epidémiologie
Characteristics of patients with rheumatoid arthritis in France : a study of 1109 patients managed by hospital based rhumatologists
SANY J, BOURGEOIS P, SARAUX A, DURIEUX S, LAFUMA A, DAURES JP, GUILLEMIN F, SIBILIA J
Ann Rheum Dis ; 63(10):1235-1240
-
Pharmaco-Epidémiologie
Blindness, low vision, and other handicaps as risk factors attached to institutional residence
BREZIN A,LAFUMA A, FAGNANI F, MESBAH M, BERDEAUX G
Br J Ophtalmol ; 88(10):1330-1337
-
Pharmaco-Epidémiologie
An epidemiological model of genital herpes : application to France
BOELLE PY, DETOURNAY B, VALLERON PJ, FAGNANI F, HALIOUA B, NICOLAS JC
Ann Dermatol Venereol ; 131(1 Pt 1):17-26
-
Pharmaco-Epidémiologie
A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries
SALTI I, BĂNARD E, DETOURNAY B, BIANCHI-BISCAY M, LE BRIGAND C, VOINET C, JABBAR A
Diabetes Care ; 27(10):2306-2311
-
Pharmaco-Epidémiologie
A multicenter pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999
LORTHOLARY O, CHARLEMAGNE A, BASTIDES F, CHEVALIER P, DATRY A, GONZALVES MF, MICHEL G, TILLEUL P, VEBER B, HERBRECHT R
J Antimicrob Chemother ; 54(2):456-64
-
Santé publique
Un modĂšle Ă©pidĂ©miologique de l’herpĂšs gĂ©nital pour l’Ă©valuation des interventions thĂ©rapeutiques et prophylactiques : application Ă la France
BOĂLLE PY, FAGNANI F, VALLERON AJ, DETOURNAY B, EL HASNAOUI A, HALIOUA B, NICOLAS JC
Ann Dermatol Venereol ; 131:17-26
-
Ăconomie de la santĂ©
Medical predictive Factors of Glaucoma Treatment Costs
DENIS P, LAFUMA A, BERDEAUX G
J Glaucoma ; 13(4):283-290
-
Ăconomie de la santĂ©
Le point de vue de l’Ă©conomiste de la santĂ© in « Evaluation des mĂ©dicaments aprĂšs la commercialisation – IntĂ©rĂȘts, objectifs et consĂ©quence
FAGNANI F
John Libbey Eurotext ; 59-62
  Â